IRAMINE TABLETS

Nazione: Australia

Lingua: inglese

Fonte: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Principio attivo:

CHLORPHENIRAMINE MALEATE

Commercializzato da:

MAVLAB PTY. LTD.

INN (Nome Internazionale):

chlorpheniramine as maleate(2.8mg/Tb)

Forma farmaceutica:

ORAL TABLET

Composizione:

CHLORPHENIRAMINE MALEATE ANTIHISTAMINE Active 4.0 mg/Tb

Confezione:

100 Tabs; 1000Tabs

Classe:

VM - Veterinary Medicine

Gruppo terapeutico:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Area terapeutica:

DERMATOLOGICAL PREPS.

Indicazioni terapeutiche:

PRURITIS | ALLERGIC SKIN DISORDER

Dettagli prodotto:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [PRURITIS]; DOG: [PRURITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [PRURITIS]; DOG: [PRURITIS]; For the relief of pruritus associated with allergic skin disorders in dogs and cats.Do not use in animals with glaucoma, prostate disease, stomach or intestinal obstruction, urinary obstruction, certain heart or lung diseases, high blood pressure or hyperthyroidism. Do not use in pregnant or lactating animals

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2023-07-01

Foglio illustrativo

APPROVED
LABEL
NAME:
APPLICANT:
FILE NAME: DIMENSION:
SCALE:
NATURES ANSWER PERNAEASE POWDER
MAVLAB PTY LTD
59494_35924_250G_ LABEL_ MPL_V2
ACTUAL LABEL SIZE = (270MM WIDE X 50MM DEEP)
100% LABEL SIZE
NAME:
APPLICANT:
FILE NAME: DIMENSION:
SCALE:
DATE:
IRAMINE TABLETS (1000 TABLETS)
MAVLAB PTY LTD
53915_39282_1000T_PRIMARY_MPL_V1
ACTUAL LABEL SIZE = (137MM WIDE X 52MM DEEP)
100% LABEL SIZE
19/09/2006
APPROVED
LABEL

Scheda tecnica

MAVLAB 
PTY 
LTD 
      Date 
of 
Issue: 
October 
2008 
    MATERIAL 
SAFETY 
DATA 
SHEET 
IRAMINE 4 MG  

Page 1 of 4 

MSDS version: 
3 
Date of Revision: 
October 2008 
Update of section: 
All sections 

SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER 
Product (material) name:   
Iramine Tablets 
Other names: 

4 mg Chlorpheniramine Tablets; C3100 
Recommended use: 

For the relief of pruritus associated with allergic
skin disorders in dogs and cats 
Supplier Details:   

Mavlab Pty Ltd ACN 068 507 148 
    31 
– 
33 
Rowland 
Street 

SLACKS CREEK    QLD    4127 
Contact 
Person: 
  Dr 
Paul 
Ross 
Emergency Telephone: 

[phone] 
Facsimile: 
  (07) 
3808 
4328 
SECTION 2 HAZARDS IDENTIFICATION 
This product not dangerous goods under the Australian Code for
the Transport of Dangerous Goods by Road and 
Rail (ADG Code) but is classified as hazardous according to the
classification criteria of NOHSC:1008(2004), 
Approved Criteria For Classifying Hazardous Substances and
the National Code of Practice for the Preparation of 
Material Safety Data Sheets 2
nd
 Edition [NOHSC:2011(2003)] 

Although this material could be classified as dangerous goods
on the basis of its toxicity, the pack sizes in which it is 
supplied are below the minimum size for such a classification under
the ADG Code. 
Health Effects  
Risk Phrase: 

R25 - Toxic if swallowed. 
Safety Phrases:   
S36/37/39-45 - Wear suitable protective clothing, gloves, and
eye/face protection.  In case 

of accident or if you feel unwell, seek medical advice immediately
(show the label where  
   possible). 
This material is presented in tablet form and it is therefore not
expected to pose inhalational or dermal health 
hazards.  However, if tablet integrity is compromised and dust is
generated, both dermal and i